Melanoma development can be influenced by mutations in several genes, such as CDKN2A (p16), CDK4 (found on chromosome 12q15), RB1, CDKN2A (p19), and PTEN/MMAC1 that can be targeted for systemic therapy [10]. Here, CDKN2A is linked to melanoma.